LipoMedix Announces Publication of Positive Phase 1 Data for Promitil® (PL-MLP) in Research Journal Investigational New Drugs
Rafael Holdings, Inc. Class B (RFL)
NASDAQ:AMEX Investor Relations:
morningstar.com/funds/xnas/rytnx/quote.html
Company Research
Source: GlobeNewswire
JERUSALEM, Jan. 23, 2020 (GLOBE NEWSWIRE) -- LipoMedix, a clinical-stage, oncology-focused pharmaceutical company, involved in the development of innovative, safe and effective cancer therapy based on a pegylated liposomal drug delivery platform, today announced that Phase 1 data of Promitil® (PL-MLP) in patients with metastatic colorectal cancer (CRC) was published in the research journal Investigational New Drugs. The study demonstrated positive results on the pharmacokinetics and clinical observations of the drug. This study analyzed 53 patients with advanced, treatment-refractory CRC treated with Promitil either as a single agent or in combination with capecitabine and/or bevacizumab. Promitil was well-tolerated with a good safety profile, as previously reported. Promitil treatment resulted in a substantial rate of disease stabilization, reported in 15 out of 36 efficacy-evaluable patients (42%). Prolonged survival of stable disease patients was also observed, with a median s
Show less
Read more
Impact Snapshot
Event Time:
RFL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RFL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RFL alerts
High impacting Rafael Holdings, Inc. Class B news events
Weekly update
A roundup of the hottest topics
RFL
Sec Filings
- 6/28/24 - Form 4
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- RFL's page on the SEC website